Age-dependent oxidative stress-induced DNA damage in Down's lymphocytes

Biochemical and Biophysical Research Communications

Volumn 345, Issue 2, 2006, Pages 726-733

  Zana, Marianna ^a   Szécsényi, Anita ^b   Czibula, Ágnes ^b   Bjelik, Annamária ^a   Juhász, Anna ^a   Rimanóczy, Ágnes ^a   Szabó, Krisztina ^a   Vetró, Ágnes ^a   Szucs, Péter ^c   Várkonyi, Ágnes ^a   Pákáski, Magdolna ^a   Boda, Krisztina ^a   Raskó, István ^b   Janka, Zoltán ^a   Kálmán, János ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Children's Medical Home   (Hungary)

Author keywords

Alzheimer's disease; Comet assay; DNA repair; Down's syndrome; Lymphocyte; Oxidative stress

Indexed keywords

HYDROGEN PEROXIDE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SINGLE STRANDED DNA;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; ARTICLE; CHILD; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DOWN SYNDROME; FEMALE; HUMAN; IN VITRO STUDY; LYMPHOCYTE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHILD; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DOWN SYNDROME; FEMALE; HUMANS; LYMPHOCYTES; MALE; OXIDATIVE STRESS;

EID: 33646905061     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.167     Document Type: Article

References (58)

1. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat. Med. 10 (2004) S18-S25
2. Korenberg J.R., Kawashima H., Pulst S.M., Ikeuchi T., Ogasawara N., Yamamoto K., Schonberg S.A., West R., Allen L., and Magenis E. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am. J. Hum. Genet. 47 (1990) 236-246
3. Pogribna M., Melnyk S., Pogribny I., Chango A., Yi P., and James S.J. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am. J. Hum. Genet. 69 (2001) 88-95
4. Mrak R.E., and Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26 (2005) 349-354
5. Schuchmann S., and Heinemann U. Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: a model of Down's syndrome. Free Radic. Biol. Med. 28 (2000) 235-250
6. Mann D.M., Royston M.C., and Ravindra C.R. Some morphometric observations on the brains of patients with Down's syndrome: their relationship to age and dementia. J. Neurol. Sci. 99 (1990) 153-164
7. Head E., Garzon-Rodriguez W., Johnson J.K., Lott I.T., Cotman C.W., and Glabe C. Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome. Neurobiol. Dis. 8 (2001) 792-806
8. Leverenz J.B., and Raskind M.A. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis. Exp. Neurol. 150 (1998) 296-304
9. Lott I.T., and Head E. Alzheimer disease and Down syndrome: factors in pathogenesis. Neurobiol. Aging 26 (2005) 383-389
10. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38 (1995) 357-366
11. Markesbery W.R., and Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19 (1998) 33-36
12. Odetti P., Angelini G., Dapino D., Zaccheo D., Garibaldi S., Dagna-Bricarelli F., Piombo G., Perry G., Smith M., Traverso N., and Tabaton M. Early glycoxidation damage in brains from Down's syndrome. Biochem. Biophys. Res. Commun. 243 (1998) 849-851
13. Schuessel K., Leutner S., Cairns N.J., Muller W.E., and Eckert A. Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J. Neural Transm. 111 (2004) 1167-1182
14. Mecocci P., MacGarvey U., and Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36 (1994) 747-751
15. Gabbita S.P., Lovell M.A., and Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71 (1998) 2034-2040
16. Seidl R., Greber S., Schuller E., Bernert G., Cairns N., and Lubec G. Evidence against increased oxidative DNA-damage in Down syndrome. Neurosci. Lett. 235 (1997) 137-140
17. Kalman J., Dey I., Ilona S.V., Matkovics B., Brown D., Janka Z., Farkas T., and Joo F. Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia. Biol. Psychiatry 35 (1994) 190-194
18. Thome J., Munch G., Muller R., Schinzel R., Kornhuber J., Blum-Degen D., Sitzmann L., Rosler M., Heidland A., and Riederer P. Advanced glycation end products-associated parameters in the peripheral blood of patients with Alzheimer's disease. Life Sci. 59 (1996) 679-685
19. Jovanovic S.V., Clements D., and MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic. Biol. Med. 25 (1998) 1044-1048
20. Pratico D., Iuliano L., Amerio G., Tang L.X., Rokach J., Sabatino G., and Violi F. Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo. Ann. Neurol. 48 (2000) 795-798
21. Muchova J., Sustrova M., Garaiova I., Liptakova A., Blazicek P., Kvasnicka P., Pueschel S., and Durackova Z. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic. Biol. Med. 31 (2001) 499-508
22. Cecchi C., Fiorillo C., Sorbi S., Latorraca S., Nacmias B., Bagnoli S., Nassi P., and Liguri G. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic. Biol. Med. 33 (2002) 1372-1379
23. Choi J., Malakowsky C.A., Talent J.M., Conrad C.C., and Gracy R.W. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem. Biophys. Res. Commun. 293 (2002) 1566-1570
24. Morale M.C., Batticane N., Cioni M., and Marchetti B. Upregulation of lymphocyte beta-adrenergic receptor in Down's syndrome: a biological marker of a neuroimmune deficit. J. Neuroimmunol. 38 (1992) 185-198
25. Peeters M.A., Salabelle A., Attal N., Rethore M.O., Mircher C., Laplane D., and Lejeune J. Excessive glutamine sensitivity in Alzheimer's disease and Down syndrome lymphocytes. J. Neurol. Sci. 133 (1995) 31-41
26. Tam C.F., and Walford R.L. Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of aging normal humans and patients with Down's syndrome. J. Immunol. 125 (1980) 1665-1670
27. Morimoto K., Kaneko T., Iijima K., and Koizumi A. Proliferative kinetics and chromosome damage in trisomy 21 lymphocyte cultures exposed to gamma-rays and bleomycin. Cancer Res. 44 (1984) 1499-1504
28. Morocz M., Kalman J., Juhasz A., Sinko I., McGlynn A.P., Downes C.S., Janka Z., and Rasko I. Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease. Neurobiol. Aging 23 (2002) 47-53
29. Kadioglu E., Sardas S., Aslan S., Isik E., and Esat K.A. Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease. Biomarkers 9 (2004) 203-209
30. Migliore L., Fontana I., Trippi F., Colognato R., Coppede F., Tognoni G., Nucciarone B., and Siciliano G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol. Aging 26 (2005) 567-573
31. Brugge K., Nichols S., Saitoh T., and Trauner D. Correlations of glutathione peroxidase activity with memory impairment in adults with Down syndrome. Biol. Psychiatry 46 (1999) 1682-1689
32. Begni B., Brighina L., Fumagalli L., Andreoni S., Castelli E., Francesconi C., Del Bo R., Bresolin N., and Ferrarese C. Altered glutamate uptake in peripheral tissues from Down syndrome patients. Neurosci. Lett. 343 (2003) 73-76
33. Collins A., Dusinska M., Franklin M., Somorovska M., Petrovska H., Duthie S., Fillion L., Panayiotidis M., Raslova K., and Vaughan N. Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ. Mol. Mutagen. 30 (1997) 139-146
34. Collins A.R., Dobson V.L., Dusinska M., Kennedy G., and Stetina R. The comet assay: what can it really tell us?. Mutat. Res. 375 (1997) 183-193
35. Collins A.R., Ma A.G., and Duthie S.J. The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. Mutat. Res. 336 (1995) 69-77
36. Collins A.R., Dusinska M., Gedik C.M., and Stetina R. Oxidative damage to DNA: do we have a reliable biomarker?. Environ. Health Perspect. 104 Suppl 3 (1996) 465-469
37. Collins A.R. Oxidative DNA damage, antioxidants, and cancer. Bioessays 21 (1999) 238-246
38. Migliore L., Fontana I., Colognato R., Coppede F., Siciliano G., and Murri L. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiol. Aging 26 (2005) 587-595
39. Asahara H., Wistort P.M., Bank J.F., Bakerian R.H., and Cunningham R.P. Purification and characterization of Escherichia coli endonuclease III from the cloned nth gene. Biochemistry 28 (1989) 4444-4449
40. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat. Res. 275 (1992) 331-342
41. Boiteux S., Gajewski E., Laval J., and Dizdaroglu M. Substrate specificity of the Escherichia coli Fpg protein (formamidopyrimidine-DNA glycosylase): excision of purine lesions in DNA produced by ionizing radiation or photosensitization. Biochemistry 31 (1992) 106-110
42. Kruszewski M., Wojewodzka M., Iwanenko T., Collins A.R., and Szumiel I. Application of the comet assay for monitoring DNA damage in workers exposed to chronic low-dose irradiation. II. Base damage. Mutat. Res. 416 (1998) 37-57
43. Maluf S.W., and Erdtmann B. Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis and single-cell gel electrophoresis. Cancer Genet. Cytogenet. 124 (2001) 71-75
44. Wojewodzka M., Kruszewski M., Iwanenko T., Collins A.R., and Szumiel I. Application of the comet assay for monitoring DNA damage in workers exposed to chronic low-dose irradiation. I. Strand breakage. Mutat. Res. 416 (1998) 21-35
45. Pastore A., Tozzi G., Gaeta L.M., Giannotti A., Bertini E., Federici G., Digilio M.C., and Piemonte F. Glutathione metabolism and antioxidant enzymes in children with Down syndrome. J. Pediatr. 142 (2003) 583-585
46. Zitnanova I., Korytar P., Aruoma O.I., Sustrova M., Garaiova I., Muchova J., Kalnovicova T., Pueschel S., and Durackova Z. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?. Clin. Chim. Acta 341 (2004) 139-146
47. Montine T.J., Quinn J.F., Milatovic D., Silbert L.C., Dang T., Sanchez S., Terry E., Roberts L.J., Kaye J.A., and Morrow J.D. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann. Neurol. 52 (2002) 175-179
48. Takeshita T., Ariizumi-Shibusawa C., Shimizu K., Hoshino H., Yamagata Z., Iijima S., Asaka A., and Higurashi M. The effect of aging on cell-cycle kinetics and X-ray-induced chromosome aberrations in cultured lymphocytes from patients with Down syndrome. Mutat. Res. 275 (1992) 21-29
49. Raji N.S., and Rao K.S. Trisomy 21 and accelerated aging: DNA-repair parameters in peripheral lymphocytes of Down's syndrome patients. Mech. Ageing Dev. 100 (1998) 85-101
50. Seeberg E., Eide L., and Bjoras M. The base excision repair pathway. Trends Biochem. Sci. 20 (1995) 391-397
51. Jaruga P., and Dizdaroglu M. Repair of products of oxidative DNA base damage in human cells. Nucleic Acids Res. 24 (1996) 1389-1394
52. Pallister C., Jung S.S., Shaw I., Nalbantoglu J., Gauthier S., and Cashman N.R. Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging. Neurobiol. Aging 18 (1997) 97-103
53. Choi J., Rees H.D., Weintraub S.T., Levey A.I., Chin L.S., and Li L. Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J. Biol. Chem. 280 (2005) 11648-11655
54. Park E., Alberti J., Mehta P., Dalton A., Sersen E., and Schuller-Levis G. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin. Immunol. 95 (2000) 62-69
55. + lymphocytes in Alzheimer's disease and in older persons with Down's syndrome. Neurobiol. Aging 14 (1993) 177-185
56. Morillas M.J., Guillamet E., Surralles J., Creus A., and Marcos R. Spontaneous and induced genetic damage in T lymphocyte subsets evaluated by the Comet assay. Mutat. Res. 514 (2002) 39-48
57. Zigman W.B., Schupf N., Sersen E., and Silverman W. Prevalence of dementia in adults with and without Down syndrome. Am. J. Ment. Retard. 100 (1996) 403-412
58. Visser F.E., Aldenkamp A.P., van Huffelen A.C., Kuilman M., Overweg J., and van Wijk J. Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. Am. J. Ment. Retard. 101 (1997) 400-412